Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 437.70M | 496.20M | 478.10M | 494.10M | 518.20M |
Gross Profit | 133.00M | 135.90M | 127.20M | 109.50M | 94.40M |
EBITDA | 112.40M | 24.40M | 64.90M | 21.80M | 3.90M |
Net Income | 46.30M | -62.40M | 8.00M | -28.20M | -57.30M |
Balance Sheet | |||||
Total Assets | 511.30M | 558.20M | 609.00M | 624.90M | 622.90M |
Cash, Cash Equivalents and Short-Term Investments | 86.20M | 77.50M | 53.60M | 68.00M | 23.90M |
Total Debt | 194.10M | 279.00M | 242.10M | 253.50M | 221.90M |
Total Liabilities | 321.00M | 409.60M | 390.70M | 414.30M | 387.00M |
Stockholders Equity | 189.90M | 148.00M | 217.80M | 209.90M | 235.20M |
Cash Flow | |||||
Free Cash Flow | 17.60M | 6.60M | 11.50M | 25.30M | 66.20M |
Operating Cash Flow | 49.30M | 37.80M | 44.50M | 48.90M | 86.60M |
Investing Cash Flow | 79.70M | -4.70M | -15.80M | -1.90M | -22.80M |
Financing Cash Flow | -131.60M | -27.40M | -40.10M | -26.10M | -56.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £532.21M | 10.85 | 10.79% | 11.49% | 8.17% | 27.93% | |
76 Outperform | £178.05M | 3.83 | 27.40% | ― | -11.79% | ― | |
76 Outperform | £104.54M | 4.80 | 12.33% | 0.32% | 8.36% | ― | |
74 Outperform | $1.01B | 11.84 | 18.20% | 3.45% | 3.44% | 0.89% | |
68 Neutral | £2.99B | 10.39 | 7.71% | 3.37% | 3.01% | -10.61% | |
67 Neutral | £67.17M | 11.18 | 7.45% | 8.29% | -2.90% | ― | |
51 Neutral | £187.38M | ― | -135.03% | ― | 8.30% | -346.39% |
James Fisher and Sons plc has applied for a block listing of 228,748 ordinary shares on the London Stock Exchange and the Financial Conduct Authority. These shares will support the vesting of share awards under the company’s 2021 Long Term Incentive Plan, with the block admission expected to be effective from 27 May 2025.
The most recent analyst rating on (GB:FSJ) stock is a Buy with a £4.00 price target. To see the full list of analyst forecasts on James Fisher & Sons stock, see the GB:FSJ Stock Forecast page.
James Fisher and Sons plc announced that all resolutions proposed at their Annual General Meeting on May 13, 2025, were successfully passed. This includes the re-election of several directors, the re-appointment of KPMG LLP as auditors, and the approval of the 2015 Sharesave Plan. The approval of these resolutions reflects strong shareholder support and positions the company to continue its strategic initiatives, potentially enhancing its market presence and operational efficiency.
The most recent analyst rating on (GB:FSJ) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on James Fisher & Sons stock, see the GB:FSJ Stock Forecast page.
James Fisher & Sons plc announced the granting of conditional awards of ordinary shares to its Executive Directors under the 2021 Long Term Incentive Plan. The awards, which were made to CEO Jean Vernet and CFO Karen Hayzen-Smith, will vest after three years, subject to performance conditions, with a two-year post-vesting holding period. This move is part of the company’s strategy to align executive interests with long-term shareholder value and ensure sustained leadership performance.
James Fisher & Sons plc has announced the granting of conditional awards over ordinary shares to its Executive Directors under the company’s Deferred Bonus Plan. On April 24, 2025, CEO Jean Vernet and CFO Karen Hayzen-Smith received awards of 81,219 and 52,427 shares respectively. These awards are structured to vest on the second anniversary of the grant date, reflecting the company’s commitment to aligning executive incentives with long-term shareholder value. This move is likely to strengthen the company’s leadership stability and align executive interests with those of stakeholders.